# C_2021039EN.01000601.xml

| 4.2.2021 | EN | Official Journal of the European Union | C 39/6 |
| --- | --- | --- | --- |

4.2.2021

EN

Official Journal of the European Union

C 39/6

---

Medicinal products – List of marketing authorisations granted by the EEA EFTA States for the first half of 2020

(2021/C 39/04)

Subcommittee I on the free movement of goods

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 January-30 June 2020, at their meeting on 25 September 2020.

| Annex I | List of new marketing authorisations |
| --- | --- |

Annex I

| Annex II | List of renewed marketing authorisations |
| --- | --- |

Annex II

| Annex III | List of extended marketing authorisations |
| --- | --- |

Annex III

| Annex IV | List of withdrawn marketing authorisations |
| --- | --- |

Annex IV

| Annex V | List of suspended marketing authorisations |
| --- | --- |

Annex V

---

ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January-30 June 2020:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/19/1415 | Amsparity | Iceland | 19.2.2020 |
| EU/1/19/1415 | Amsparity | Liechtenstein | 29.2.2020 |
| EU/1/19/1415 | Amsparity | Norway | 20.2.2020 |
| EU/1/20/1427 | Arsenic trioxide Mylan | Iceland | 20.4.2020 |
| EU/1/20/1427 | Arsenic trioxide Mylan | Liechtenstein | 30.4.2020 |
| EU/1/20/1427 | Arsenic trioxide Mylan | Norway | 14.4.2020 |
| EU/2/19/249 | Aservo EquiHaler | Iceland | 18.2.2020 |
| EU/2/19/249 | Aservo EquiHaler | Liechtenstein | 29.2.2020 |
| EU/2/19/249 | Aservo EquiHaler | Norway | 5.3.2020 |
| EU/1/20/1439 | Atectura Breezhaler | Iceland | 23.6.2020 |
| EU/1/20/1439 | Atectura Breezhaler | Liechtenstein | 30.6.2020 |
| EU/1/20/1439 | Atectura Breezhaler | Norway | 8.6.2020 |
| EU/1/19/1413 | Azacitidine Accord | Iceland | 19.2.2020 |
| EU/1/19/1413 | Azacitidine Accord | Liechtenstein | 29.2.2020 |
| EU/1/19/1413 | Azacitidine Accord | Norway | 21.2.2020 |
| EU/1/19/1416 | Azacitidine Betapharm | Iceland | 16.4.2020 |
| EU/1/19/1416 | Azacitidine Betapharm | Liechtenstein | 30.4.2020 |
| EU/1/19/1416 | Azacitidine Betapharm | Norway | 31.3.2020 |
| EU/1/20/1426 | Azacitidine Mylan | Iceland | 17.4.2020 |
| EU/1/20/1426 | Azacitidine Mylan | Liechtenstein | 30.4.2020 |
| EU/1/20/1426 | Azacitidine Mylan | Norway | 2.4.2020 |
| EU/1/19/1406 | Baqsimi | Norway | 13.1.2020 |
| EU/1/20/1441 | Bemrist Breezhaler | Iceland | 22.6.2020 |
| EU/1/20/1441 | Bemrist Breezhaler | Liechtenstein | 30.6.2020 |
| EU/1/20/1441 | Bemrist Breezhaler | Norway | 8.6.2020 |
| EU/1/19/1417 | Beovu | Iceland | 18.2.2020 |
| EU/1/19/1417 | Beovu | Liechtenstein | 29.2.2020 |
| EU/1/19/1417 | Beovu | Norway | 19.2.2020 |
| EU/1/19/1403 | Budesonide/Formoterol Teva Pharma B.V. | Iceland | 22.5.2020 |
| EU/1/19/1403 | Budesonide/Formoterol Teva Pharma B.V. | Liechtenstein | 30.4.2020 |
| EU/1/19/1403 | Budesonide/Formoterol Teva Pharma B.V. | Norway | 14.4.2020 |
| EU/1/19/1409 | Cegfila | Iceland | 9.1.2020 |
| EU/1/20/1429 | Cinacalcet Accordpharma | Iceland | 21.4.2020 |
| EU/1/20/1429 | Cinacalcet Accordpharma | Norway | 14.4.2020 |
| EU/1/19/1395 | Clopidogrel/Acetylsalicylic acid Mylan | Iceland | 20.1.2020 |
| EU/1/19/1395 | Clopidogrel/Acetylsalicylic acid Mylan | Norway | 7.2.2020 |
| EU/1/20/1451 | Daurismo | Liechtenstein | 30.6.2020 |
| EU/1/19/1412 | Deferasirox Accord | Iceland | 15.1.2020 |
| EU/1/19/1412 | Deferasirox Accord | Norway | 22.1.2020 |
| EU/1/19/1418 | Dexmedetomidin Accord | Iceland | 18.2.2020 |
| EU/1/19/1418 | Dexmedetomidin Accord | Liechtenstein | 29.2.2020 |
| EU/1/19/1418 | Dexmedetomidin Accord | Norway | 19.2.2020 |
| EU/1/19/1411 | Evenity | Norway | 3.1.2020 |
| EU/1/20/1434 | Fetcroja | Iceland | 19.5.2020 |
| EU/1/20/1434 | Fetcroja | Liechtenstein | 30.4.2020 |
| EU/1/20/1434 | Fetcroja | Norway | 8.5.2020 |
| EU/1/20/1450 | Fingolimod Accord | Liechtenstein | 30.6.2020 |
| EU/1/20/1433 | Fluad Tetra | Iceland | 16.6.2020 |
| EU/1/20/1433 | Fluad Tetra | Liechtenstein | 30.6.2020 |
| EU/1/20/1433 | Fluad Tetra | Norway | 2.6.2020 |
| EU/1/20/1428 | Givlaari | Iceland | 20.3.2020 |
| EU/1/20/1428 | Givlaari | Liechtenstein | 30.4.2020 |
| EU/1/20/1428 | Givlaari | Norway | 6.3.2020 |
| EU/2/19/245 | Gumbohatch | Norway | 29.6.2020 |
| EU/1/20/1447 | Insulin aspart Sanofi | Liechtenstein | 30.6.2020 |
| EU/1/19/1407 | Isturisa | Liechtenstein | 29.2.2020 |
| EU/1/19/1407 | Isturisa | Iceland | 16.1.2020 |
| EU/1/19/1407 | Isturisa | Liechtenstein | 30.4.2020 |
| EU/1/19/1407 | Isturisa | Norway | 3.2.2020 |
| EU/1/20/1422 | Liumjev | Iceland | 17.4.2020 |
| EU/1/20/1422 | Liumjev | Liechtenstein | 30.4.2020 |
| EU/1/20/1422 | Liumjev | Norway | 31.3.2020 |
| EU/2/20/253 | Lydaxx | Iceland | 2.6.2020 |
| EU/2/20/253 | Lydaxx | Norway | 9.6.2020 |
| EU/1/19/1414 | Mayzent | Iceland | 21.2.2020 |
| EU/1/19/1414 | Mayzent | Liechtenstein | 29.2.2020 |
| EU/1/19/1414 | Mayzent | Norway | 27.1.2020 |
| EU/1/20/1436 | Nepexto | Iceland | 16.6.2020 |
| EU/1/20/1436 | Nepexto | Liechtenstein | 30.6.2020 |
| EU/1/20/1436 | Nepexto | Norway | 9.6.2020 |
| EU/2/19/246 | Neptra | Norway | 6.1.2020 |
| EU/1/20/1425 | Nilemdo | Iceland | 20.4.2020 |
| EU/1/20/1425 | Nilemdo | Liechtenstein | 30.4.2020 |
| EU/1/20/1425 | Nilemdo | Norway | 15.4.2020 |
| EU/1/20/1432 | Nubeqa | Iceland | 17.4.2020 |
| EU/1/20/1432 | Nubeqa | Liechtenstein | 30.4.2020 |
| EU/1/20/1432 | Nubeqa | Norway | 1.4.2020 |
| EU/1/20/1424 | Nustendi | Iceland | 17.4.2020 |
| EU/1/20/1424 | Nustendi | Norway | 3.4.2020 |
| EU/1/20/1453 | Paliperidone Janssen-Cilag International | Iceland | 26.6.2020 |
| EU/1/20/1453 | Paliperidone Janssen-Cilag International | Liechtenstein | 30.6.2020 |
| EU/1/20/1453 | Paliperidone Janssen-Cilag International | Norway | 29.6.2020 |
| EU/1/19/1409 | Pegfilgrastim Mundipharma | Norway | 9.1.2020 |
| EU/1/19/1388 | Polivy | Iceland | 24.1.2020 |
| EU/1/19/1388 | Polivy | Liechtenstein | 29.2.2020 |
| EU/1/19/1388 | Polivy | Norway | 27.1.2020 |
| EU/1/19/1393 | Quofenix | Norway | 9.1.2020 |
| EU/1/20/1452 | Reblozyl | Liechtenstein | 30.6.2020 |
| EU/1/19/1420 | Recarbrio | Iceland | 18.2.2020 |
| EU/1/19/1420 | Recarbrio | Liechtenstein | 29.2.2020 |
| EU/1/19/1420 | Recarbrio | Liechtenstein | 30.4.2020 |
| EU/1/19/1420 | Recarbrio | Norway | 19.2.2020 |
| EU/1/19/1420 | Recarbrio | Norway | 23.4.2020 |
| EU/1/20/1430 | Rybelsus | Liechtenstein | 30.4.2020 |
| EU/1/19/1404 | Rinvoq | Norway | 3.1.2020 |
| EU/1/20/1431 | Ruxience | Iceland | 20.4.2020 |
| EU/1/20/1431 | Ruxience | Norway | 14.4.2020 |
| EU/1/20/1430 | Rybelsus | Iceland | 22.4.2020 |
| EU/1/20/1430 | Rybelsus | Norway | 14.4.2020 |
| EU/1/20/1435 | Sarclisa | Iceland | 23.6.2020 |
| EU/1/20/1435 | Sarclisa | Norway | 12.6.2020 |
| EU/1/19/1387 | Senstend | Liechtenstein | 29.2.2020 |
| EU/1/19/1410 | Spravato | Iceland | 3.1.2020 |
| EU/1/19/1410 | Spravato | Norway | 15.1.2020 |
| EU/1/19/1421 | Staquis | Iceland | 20.4.2020 |
| EU/1/19/1421 | Staquis | Norway | 3.4.2020 |
| EU/2/19/248 | Stelfonta | Iceland | 20.2.2020 |
| EU/2/19/248 | Stelfonta | Liechtenstein | 29.2.2020 |
| EU/2/19/248 | Stelfonta | Norway | 30.1.2020 |
| EU/1/19/1408 | Sunosi | Iceland | 24.1.2020 |
| EU/1/19/1408 | Sunosi | Liechtenstein | 29.2.2020 |
| EU/1/19/1408 | Sunosi | Norway | 27.1.2020 |
| EU/1/19/1405 | Tavlesse | Iceland | 15.1.2020 |
| EU/1/19/1405 | Tavlesse | Liechtenstein | 29.2.2020 |
| EU/1/19/1405 | Tavlesse | Norway | 7.2.2020 |
| EU/1/19/1394 | Tigecycline Accord | Iceland | 29.4.2020 |
| EU/1/19/1394 | Tigecycline Accord | Liechtenstein | 30.4.2020 |
| EU/1/19/1394 | Tigecycline Accord | Norway | 17.4.2020 |
| EU/1/19/1419 | Trepulmix | Iceland | 21.4.2020 |
| EU/1/19/1419 | Trepulmix | Liechtenstein | 30.4.2020 |
| EU/1/19/1419 | Trepulmix | Norway | 14.4.2020 |
| EU/2/20/251 | Tulaven | Iceland | 29.4.2020 |
| EU/2/20/251 | Tulaven | Liechtenstein | 30.4.2020 |
| EU/2/20/251 | Tulaven | Norway | 29.4.2020 |
| EU/2/20/252 | TULISSIN | Iceland | 19.5.2020 |
| EU/1/18/1309 | Ulipristal Acetate Gedeon Richter | Liechtenstein | 30.4.2020 |
| EU/1/20/1423 | Vaxchora | Iceland | 21.4.2020 |
| EU/1/20/1423 | Vaxchora | Liechtenstein | 30.4.2020 |
| EU/1/20/1423 | Vaxchora | Norway | 17.4.2020 |
| EU/2/20/250 | Vectormune FP ILT + AE | Iceland | 29.4.2020 |
| EU/2/20/250 | Vectormune FP ILT + AE | Liechtenstein | 30.4.2020 |
| EU/2/20/250 | Vectormune FP ILT + AE | Norway | 29.4.2020 |
| EU/1/19/1399 | Xospata | Liechtenstein | 29.2.2020 |
| EU/1/20/1442 | Zeposia | Iceland | 22.6.2020 |
| EU/1/20/1442 | Zeposia | Liechtenstein | 30.6.2020 |
| EU/1/20/1442 | Zeposia | Norway | 15.6.2020 |
| EU/1/20/1443 | Zolgensma | Iceland | 20.5.2020 |
| EU/1/20/1443 | Zolgensma | Liechtenstein | 30.6.2020 |
| EU/1/20/1443 | Zolgensma | Norway | 20.5.2020 |

EU-Number

Product

Country

Date of authorisation

EU/1/19/1415

Amsparity

Iceland

19.2.2020

EU/1/19/1415

Amsparity

Liechtenstein

29.2.2020

EU/1/19/1415

Amsparity

Norway

20.2.2020

EU/1/20/1427

Arsenic trioxide Mylan

Iceland

20.4.2020

EU/1/20/1427

Arsenic trioxide Mylan

Liechtenstein

30.4.2020

EU/1/20/1427

Arsenic trioxide Mylan

Norway

14.4.2020

EU/2/19/249

Aservo EquiHaler

Iceland

18.2.2020

EU/2/19/249

Aservo EquiHaler

Liechtenstein

29.2.2020

EU/2/19/249

Aservo EquiHaler

Norway

5.3.2020

EU/1/20/1439

Atectura Breezhaler

Iceland

23.6.2020

EU/1/20/1439

Atectura Breezhaler

Liechtenstein

30.6.2020

EU/1/20/1439

Atectura Breezhaler

Norway

8.6.2020

EU/1/19/1413

Azacitidine Accord

Iceland

19.2.2020

EU/1/19/1413

Azacitidine Accord

Liechtenstein

29.2.2020

EU/1/19/1413

Azacitidine Accord

Norway

21.2.2020

EU/1/19/1416

Azacitidine Betapharm

Iceland

16.4.2020

EU/1/19/1416

Azacitidine Betapharm

Liechtenstein

30.4.2020

EU/1/19/1416

Azacitidine Betapharm

Norway

31.3.2020

EU/1/20/1426

Azacitidine Mylan

Iceland

17.4.2020

EU/1/20/1426

Azacitidine Mylan

Liechtenstein

30.4.2020

EU/1/20/1426

Azacitidine Mylan

Norway

2.4.2020

EU/1/19/1406

Baqsimi

Norway

13.1.2020

EU/1/20/1441

Bemrist Breezhaler

Iceland

22.6.2020

EU/1/20/1441

Bemrist Breezhaler

Liechtenstein

30.6.2020

EU/1/20/1441

Bemrist Breezhaler

Norway

8.6.2020

EU/1/19/1417

Beovu

Iceland

18.2.2020

EU/1/19/1417

Beovu

Liechtenstein

29.2.2020

EU/1/19/1417

Beovu

Norway

19.2.2020

EU/1/19/1403

Budesonide/Formoterol Teva Pharma B.V.

Iceland

22.5.2020

EU/1/19/1403

Budesonide/Formoterol Teva Pharma B.V.

Liechtenstein

30.4.2020

EU/1/19/1403

Budesonide/Formoterol Teva Pharma B.V.

Norway

14.4.2020

EU/1/19/1409

Cegfila

Iceland

9.1.2020

EU/1/20/1429

Cinacalcet Accordpharma

Iceland

21.4.2020

EU/1/20/1429

Cinacalcet Accordpharma

Norway

14.4.2020

EU/1/19/1395

Clopidogrel/Acetylsalicylic acid Mylan

Iceland

20.1.2020

EU/1/19/1395

Clopidogrel/Acetylsalicylic acid Mylan

Norway

7.2.2020

EU/1/20/1451

Daurismo

Liechtenstein

30.6.2020

EU/1/19/1412

Deferasirox Accord

Iceland

15.1.2020

EU/1/19/1412

Deferasirox Accord

Norway

22.1.2020

EU/1/19/1418

Dexmedetomidin Accord

Iceland

18.2.2020

EU/1/19/1418

Dexmedetomidin Accord

Liechtenstein

29.2.2020

EU/1/19/1418

Dexmedetomidin Accord

Norway

19.2.2020

EU/1/19/1411

Evenity

Norway

3.1.2020

EU/1/20/1434

Fetcroja

Iceland

19.5.2020

EU/1/20/1434

Fetcroja

Liechtenstein

30.4.2020

EU/1/20/1434

Fetcroja

Norway

8.5.2020

EU/1/20/1450

Fingolimod Accord

Liechtenstein

30.6.2020

EU/1/20/1433

Fluad Tetra

Iceland

16.6.2020

EU/1/20/1433

Fluad Tetra

Liechtenstein

30.6.2020

EU/1/20/1433

Fluad Tetra

Norway

2.6.2020

EU/1/20/1428

Givlaari

Iceland

20.3.2020

EU/1/20/1428

Givlaari

Liechtenstein

30.4.2020

EU/1/20/1428

Givlaari

Norway

6.3.2020

EU/2/19/245

Gumbohatch

Norway

29.6.2020

EU/1/20/1447

Insulin aspart Sanofi

Liechtenstein

30.6.2020

EU/1/19/1407

Isturisa

Liechtenstein

29.2.2020

EU/1/19/1407

Isturisa

Iceland

16.1.2020

EU/1/19/1407

Isturisa

Liechtenstein

30.4.2020

EU/1/19/1407

Isturisa

Norway

3.2.2020

EU/1/20/1422

Liumjev

Iceland

17.4.2020

EU/1/20/1422

Liumjev

Liechtenstein

30.4.2020

EU/1/20/1422

Liumjev

Norway

31.3.2020

EU/2/20/253

Lydaxx

Iceland

2.6.2020

EU/2/20/253

Lydaxx

Norway

9.6.2020

EU/1/19/1414

Mayzent

Iceland

21.2.2020

EU/1/19/1414

Mayzent

Liechtenstein

29.2.2020

EU/1/19/1414

Mayzent

Norway

27.1.2020

EU/1/20/1436

Nepexto

Iceland

16.6.2020

EU/1/20/1436

Nepexto

Liechtenstein

30.6.2020

EU/1/20/1436

Nepexto

Norway

9.6.2020

EU/2/19/246

Neptra

Norway

6.1.2020

EU/1/20/1425

Nilemdo

Iceland

20.4.2020

EU/1/20/1425

Nilemdo

Liechtenstein

30.4.2020

EU/1/20/1425

Nilemdo

Norway

15.4.2020

EU/1/20/1432

Nubeqa

Iceland

17.4.2020

EU/1/20/1432

Nubeqa

Liechtenstein

30.4.2020

EU/1/20/1432

Nubeqa

Norway

1.4.2020

EU/1/20/1424

Nustendi

Iceland

17.4.2020

EU/1/20/1424

Nustendi

Norway

3.4.2020

EU/1/20/1453

Paliperidone Janssen-Cilag International

Iceland

26.6.2020

EU/1/20/1453

Paliperidone Janssen-Cilag International

Liechtenstein

30.6.2020

EU/1/20/1453

Paliperidone Janssen-Cilag International

Norway

29.6.2020

EU/1/19/1409

Pegfilgrastim Mundipharma

Norway

9.1.2020

EU/1/19/1388

Polivy

Iceland

24.1.2020

EU/1/19/1388

Polivy

Liechtenstein

29.2.2020

EU/1/19/1388

Polivy

Norway

27.1.2020

EU/1/19/1393

Quofenix

Norway

9.1.2020

EU/1/20/1452

Reblozyl

Liechtenstein

30.6.2020

EU/1/19/1420

Recarbrio

Iceland

18.2.2020

EU/1/19/1420

Recarbrio

Liechtenstein

29.2.2020

EU/1/19/1420

Recarbrio

Liechtenstein

30.4.2020

EU/1/19/1420

Recarbrio

Norway

19.2.2020

EU/1/19/1420

Recarbrio

Norway

23.4.2020

EU/1/20/1430

Rybelsus

Liechtenstein

30.4.2020

EU/1/19/1404

Rinvoq

Norway

3.1.2020

EU/1/20/1431

Ruxience

Iceland

20.4.2020

EU/1/20/1431

Ruxience

Norway

14.4.2020

EU/1/20/1430

Rybelsus

Iceland

22.4.2020

EU/1/20/1430

Rybelsus

Norway

14.4.2020

EU/1/20/1435

Sarclisa

Iceland

23.6.2020

EU/1/20/1435

Sarclisa

Norway

12.6.2020

EU/1/19/1387

Senstend

Liechtenstein

29.2.2020

EU/1/19/1410

Spravato

Iceland

3.1.2020

EU/1/19/1410

Spravato

Norway

15.1.2020

EU/1/19/1421

Staquis

Iceland

20.4.2020

EU/1/19/1421

Staquis

Norway

3.4.2020

EU/2/19/248

Stelfonta

Iceland

20.2.2020

EU/2/19/248

Stelfonta

Liechtenstein

29.2.2020

EU/2/19/248

Stelfonta

Norway

30.1.2020

EU/1/19/1408

Sunosi

Iceland

24.1.2020

EU/1/19/1408

Sunosi

Liechtenstein

29.2.2020

EU/1/19/1408

Sunosi

Norway

27.1.2020

EU/1/19/1405

Tavlesse

Iceland

15.1.2020

EU/1/19/1405

Tavlesse

Liechtenstein

29.2.2020

EU/1/19/1405

Tavlesse

Norway

7.2.2020

EU/1/19/1394

Tigecycline Accord

Iceland

29.4.2020

EU/1/19/1394

Tigecycline Accord

Liechtenstein

30.4.2020

EU/1/19/1394

Tigecycline Accord

Norway

17.4.2020

EU/1/19/1419

Trepulmix

Iceland

21.4.2020

EU/1/19/1419

Trepulmix

Liechtenstein

30.4.2020

EU/1/19/1419

Trepulmix

Norway

14.4.2020

EU/2/20/251

Tulaven

Iceland

29.4.2020

EU/2/20/251

Tulaven

Liechtenstein

30.4.2020

EU/2/20/251

Tulaven

Norway

29.4.2020

EU/2/20/252

TULISSIN

Iceland

19.5.2020

EU/1/18/1309

Ulipristal Acetate Gedeon Richter

Liechtenstein

30.4.2020

EU/1/20/1423

Vaxchora

Iceland

21.4.2020

EU/1/20/1423

Vaxchora

Liechtenstein

30.4.2020

EU/1/20/1423

Vaxchora

Norway

17.4.2020

EU/2/20/250

Vectormune FP ILT + AE

Iceland

29.4.2020

EU/2/20/250

Vectormune FP ILT + AE

Liechtenstein

30.4.2020

EU/2/20/250

Vectormune FP ILT + AE

Norway

29.4.2020

EU/1/19/1399

Xospata

Liechtenstein

29.2.2020

EU/1/20/1442

Zeposia

Iceland

22.6.2020

EU/1/20/1442

Zeposia

Liechtenstein

30.6.2020

EU/1/20/1442

Zeposia

Norway

15.6.2020

EU/1/20/1443

Zolgensma

Iceland

20.5.2020

EU/1/20/1443

Zolgensma

Liechtenstein

30.6.2020

EU/1/20/1443

Zolgensma

Norway

20.5.2020

---

ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January-30 June 2020:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/15/1001 | Akynzeo | Iceland | 15.1.2020 |
| EU/1/15/1001 | Akynzeo | Liechtenstein | 29.2.2020 |
| EU/1/15/1001 | Akynzeo | Norway | 22.1.2020 |
| EU/1/15/1005 | Aripiprazole Mylan Pharma | Iceland | 13.3.2020 |
| EU/1/15/1005 | Aripiprazole Mylan Pharma | Norway | 10.3.2020 |
| EU/1/15/1029 | Aripiprazole Sandoz | Liechtenstein | 30.6.2020 |
| EU/1/15/1009 | Aripiprazole Zentiva | Iceland | 22.6.2020 |
| EU/1/15/1009 | Aripiprazole Zentiva | Liechtenstein | 30.6.2020 |
| EU/1/15/1009 | Aripiprazole Zentiva | Norway | 18.6.2020 |
| EU/1/15/1019 | Bortezomib Accord | Iceland | 20.5.2020 |
| EU/1/15/1019 | Bortezomib Accord | Liechtenstein | 30.6.2020 |
| EU/1/15/1019 | Bortezomib Accord | Norway | 15.5.2020 |
| EU/1/13/818 | Bosulif | Iceland | 27.2.2020 |
| EU/1/13/818 | Bosulif | Liechtenstein | 29.2.2020 |
| EU/1/13/818 | Bosulif | Norway | 25.2.2020 |
| EU/1/10/645 | Brinavess | Iceland | 22.6.2020 |
| EU/1/10/645 | Brinavess | Liechtenstein | 30.6.2020 |
| EU/1/10/645 | Brinavess | Norway | 8.6.2020 |
| EU/2/15/183 | Canigen L4 | Liechtenstein | 30.4.2020 |
| EU/2/15/183 | Canigen L4 | Norway | 28.4.2020 |
| EU/1/11/749 | Caprelsa | Iceland | 21.1.2020 |
| EU/1/11/749 | Caprelsa | Liechtenstein | 29.2.2020 |
| EU/1/11/749 | Caprelsa | Norway | 23.1.2020 |
| EU/1/14/974 | Cerdelga | Norway | 3.1.2020 |
| EU/2/14/180 | Coliprotec F4 | Iceland | 24.1.2020 |
| EU/2/14/180 | Coliprotec F4 | Liechtenstein | 29.2.2020 |
| EU/2/14/180 | Coliprotec F4 | Norway | 12.2.2020 |
| EU/1/13/890 | Cometriq | Iceland | 20.3.2020 |
| EU/1/13/890 | Cometriq | Liechtenstein | 29.2.2020 |
| EU/1/13/890 | Cometriq | Liechtenstein | 30.4.2020 |
| EU/1/13/890 | Cometriq | Norway | 10.3.2020 |
| EU/1/15/1048 | Cotellic | Liechtenstein | 30.6.2020 |
| EU/1/17/1262 | Crysvita | Norway | 20.1.2020 |
| EU/1/10/636 | Daxas | Iceland | 2.6.2020 |
| EU/1/10/636 | Daxas | Liechtenstein | 30.6.2020 |
| EU/1/10/636 | Daxas | Norway | 3.6.2020 |
| EU/1/13/875 | Deltyba | Iceland | 19.5.2020 |
| EU/1/13/875 | Deltyba | Liechtenstein | 30.4.2020 |
| EU/1/13/875 | Deltyba | Norway | 30.4.2020 |
| EU/1/15/1010 | Duloxetine Mylan | Iceland | 27.2.2020 |
| EU/1/15/1010 | Duloxetine Mylan | Liechtenstein | 29.2.2020 |
| EU/1/15/1010 | Duloxetine Mylan | Norway | 24.2.2020 |
| EU/1/15/1025 | Evotaz | Norway | 8.4.2020 |
| EU/1/15/1058 | Entresto | Liechtenstein | 30.6.2020 |
| EU/1/15/1023 | Farydak | Iceland | 22.5.2020 |
| EU/1/15/1023 | Farydak | Liechtenstein | 30.4.2020 |
| EU/1/15/1023 | Farydak | Norway | 7.5.2020 |
| EU/1/15/1007 | Gardasil 9 | Iceland | 23.1.2020 |
| EU/1/15/1007 | Gardasil 9 | Liechtenstein | 29.2.2020 |
| EU/1/15/1007 | Gardasil 9 | Norway | 23.1.2020 |
| EU/1/14/987 | Holoclar | Iceland | 13.3.2020 |
| EU/1/14/987 | Holoclar | Liechtenstein | 30.4.2020 |
| EU/1/14/987 | Holoclar | Norway | 16.3.2020 |
| EU/1/15/990 | Ikervis | Iceland | 13.3.2020 |
| EU/2/15/182 | Innovax-ILT | Iceland | 30.4.2020 |
| EU/2/15/182 | Innovax-ILT | Liechtenstein | 30.4.2020 |
| EU/2/15/182 | Innovax-ILT | Norway | 5.5.2020 |
| EU/1/15/1041 | Ivabradine Anpharm | Norway | 2.6.2020 |
| EU/1/15/1040 | Intuniv | Liechtenstein | 30.6.2020 |
| EU/1/15/1000 | Jinarc | Iceland | 22.5.2020 |
| EU/1/15/1000 | Jinarc | Liechtenstein | 30.4.2020 |
| EU/1/15/1000 | Jinarc | Norway | 14.4.2020 |
| EU/1/15/1033 | Kanuma | Iceland | 22.5.2020 |
| EU/1/15/1033 | Kanuma | Liechtenstein | 30.4.2020 |
| EU/1/15/1033 | Kanuma | Norway | 23.4.2020 |
| EU/1/15/994 | Kengrexal | Norway | 13.1.2020 |
| EU/1/15/1024 | Keytruda | Iceland | 16.4.2020 |
| EU/1/15/1024 | Keytruda | Norway | 2.4.2020 |
| EU/1/15/1060 | Kyprolis | Liechtenstein | 30.6.2020 |
| EU/1/15/1002 | Lenvima | Iceland | 3.6.2020 |
| EU/1/15/1002 | Lenvima | Liechtenstein | 30.6.2020 |
| EU/1/15/1002 | Lenvima | Norway | 2.6.2020 |
| EU/1/19/1376 | Libtayo | Iceland | 2.6.2020 |
| EU/1/19/1376 | Libtayo | Liechtenstein | 30.6.2020 |
| EU/1/19/1376 | Libtayo | Norway | 2.6.2020 |
| EU/1/15/993 | Lixiana | Iceland | 13.3.2020 |
| EU/1/15/993 | Lixiana | Norway | 10.3.2020 |
| EU/1/19/1355 | Lorviqua | Iceland | 19.5.2020 |
| EU/1/19/1355 | Lorviqua | Norway | 16.4.2020 |
| EU/1/15/1013 | Lumark | Iceland | 19.5.2020 |
| EU/1/15/1013 | Lumark | Liechtenstein | 30.4.2020 |
| EU/1/15/1013 | Lumark | Norway | 5.5.2020 |
| EU/1/14/988 | Mysimba | Iceland | 23.1.2020 |
| EU/1/14/988 | Mysimba | Liechtenstein | 29.2.2020 |
| EU/1/14/988 | Mysimba | Norway | 23.1.2020 |
| EU/1/15/1078 | Natpar | Iceland | 24.6.2020 |
| EU/1/15/1078 | Natpar | Liechtenstein | 30.4.2020 |
| EU/2/15/186 | Novaquin | Liechtenstein | 30.6.2020 |
| EU/1/16/1139 | Ocaliva | Iceland | 20.5.2020 |
| EU/1/16/1139 | Ocaliva | Liechtenstein | 30.4.2020 |
| EU/1/16/1139 | Ocaliva | Norway | 12.5.2020 |
| EU/1/15/1030 | Odomzo | Iceland | 16.6.2020 |
| EU/1/15/1030 | Odomzo | Liechtenstein | 30.6.2020 |
| EU/1/15/1030 | Odomzo | Norway | 3.6.2020 |
| EU/1/18/1345 | Ondexxya | Iceland | 25.5.2020 |
| EU/1/18/1345 | Ondexxya | Liechtenstein | 30.4.2020 |
| EU/1/15/1014 | Opdivo | Iceland | 19.5.2020 |
| EU/1/15/1014 | Opdivo | Liechtenstein | 30.4.2020 |
| EU/1/15/1014 | Opdivo | Norway | 8.5.2020 |
| EU/1/15/989 | Orbactiv | Iceland | 21.1.2020 |
| EU/1/15/989 | Orbactiv | Liechtenstein | 29.2.2020 |
| EU/1/15/989 | Orbactiv | Norway | 22.1.2020 |
| EU/1/16/1089 | Pandemic influenza vaccine H5N1 AstraZeneca | Iceland | 20.3.2020 |
| EU/1/16/1089 | Pandemic influenza vaccine H5N1 AstraZeneca | Liechtenstein | 29.2.2020 |
| EU/1/16/1089 | Pandemic influenza vaccine H5N1 AstraZeneca | Liechtenstein | 30.4.2020 |
| EU/1/16/1089 | Pandemic influenza vaccine H5N1 AstraZeneca | Norway | 24.3.2020 |
| EU/1/15/1034 | Pemetrexed Lilly | Iceland | 22.6.2020 |
| EU/1/15/1034 | Pemetrexed Lilly | Liechtenstein | 30.6.2020 |
| EU/1/15/1034 | Pemetrexed Lilly | Norway | 15.6.2020 |
| EU/2/15/187 | Porcilis PCV ID | Iceland | 22.6.2020 |
| EU/2/15/187 | Porcilis PCV ID | Liechtenstein | 30.6.2020 |
| EU/1/15/1031 | Praluent | Iceland | 23.6.2020 |
| EU/1/15/1031 | Praluent | Liechtenstein | 30.6.2020 |
| EU/1/15/1031 | Praluent | Norway | 18.6.2020 |
| EU/1/15/997 | Pregabalin Mylan | Iceland | 16.4.2020 |
| EU/1/15/997 | Pregabalin Mylan | Liechtenstein | 30.4.2020 |
| EU/1/15/997 | Pregabalin Mylan | Norway | 16.4.2020 |
| EU/1/15/998 | Pregabalin Mylan Pharma | Iceland | 22.5.2020 |
| EU/1/15/998 | Pregabalin Mylan Pharma | Liechtenstein | 30.4.2020 |
| EU/1/15/998 | Pregabalin Mylan Pharma | Norway | 16.4.2020 |
| EU/1/14/916 | Pregabalin Pfizer | Norway | 10.6.2020 |
| EU/1/15/1011 | Pregabalin Sandoz | Liechtenstein | 30.6.2020 |
| EU/1/15/1012 | Pregabalin Sandoz GmbH | Liechtenstein | 30.6.2020 |
| EU/1/15/1021 | Pregabalin Zentiva | Iceland | 16.6.2020 |
| EU/1/15/1021 | Pregabalin Zentiva | Liechtenstein | 30.6.2020 |
| EU/1/15/1021 | Pregabalin Zentiva | Norway | 2.6.2020 |
| EU/2/15/187 | Porcilis PCV ID | Norway | 9.6.2020 |
| EU/1/10/618 | Prolia | Iceland | 23.1.2020 |
| EU/1/10/618 | Prolia | Liechtenstein | 29.2.2020 |
| EU/1/14/973 | Quinsair | Iceland | 19.2.2020 |
| EU/1/14/973 | Quinsair | Liechtenstein | 29.2.2020 |
| EU/1/14/973 | Quinsair | Norway | 19.2.2020 |
| EU/1/15/1016 | Repatha | Iceland | 22.4.2020 |
| EU/1/15/1016 | Repatha | Liechtenstein | 30.4.2020 |
| EU/1/15/1016 | Repatha | Norway | 22.4.2020 |
| EU/1/15/1006 | Respreeza | Iceland | 22.5.2020 |
| EU/1/15/1006 | Respreeza | Liechtenstein | 30.4.2020 |
| EU/1/15/1006 | Respreeza | Norway | 28.4.2020 |
| EU/1/17/1250 | Rubraca | Iceland | 22.5.2020 |
| EU/1/17/1250 | Rubraca | Liechtenstein | 30.4.2020 |
| EU/1/17/1250 | Rubraca | Norway | 23.4.2020 |
| EU/1/15/992 | Saxenda | Norway | 3.1.2020 |
| EU/2/15/181 | Sileo | Iceland | 19.5.2020 |
| EU/2/15/181 | Sileo | Liechtenstein | 30.4.2020 |
| EU/2/15/181 | Sileo | Norway | 12.5.2020 |
| EU/1/13/901 | Sirturo | Iceland | 15.1.2020 |
| EU/1/13/901 | Sirturo | Liechtenstein | 29.2.2020 |
| EU/1/13/901 | Sirturo | Norway | 23.1.2020 |
| EU/1/15/991 | Sivextro | Iceland | 15.1.2020 |
| EU/1/15/991 | Sivextro | Liechtenstein | 29.2.2020 |
| EU/1/15/991 | Sivextro | Norway | 22.1.2020 |
| EU/1/15/1015 | Strensiq | Iceland | 20.5.2020 |
| EU/1/15/1015 | Strensiq | Norway | 5.5.2020 |
| EU/1/15/1003 | Synjardy | Iceland | 16.4.2020 |
| EU/1/15/1003 | Synjardy | Liechtenstein | 30.4.2020 |
| EU/1/15/1003 | Synjardy | Norway | 14.4.2020 |
| EU/1/15/1004 | Voriconazole Hikma | Iceland | 25.5.2020 |
| EU/1/15/1004 | Voriconazole Hikma | Norway | 24.3.2020 |
| EU/1/19/1360 | Waylivra | Iceland | 21.3.2020 |
| EU/1/19/1360 | Waylivra | Liechtenstein | 30.4.2020 |
| EU/1/19/1360 | Waylivra | Norway | 26.5.2020 |
| EU/1/15/1032 | Zerbaxa | Iceland | 30.4.2020 |
| EU/1/15/1032 | Zerbaxa | Liechtenstein | 30.4.2020 |
| EU/1/15/1032 | Zerbaxa | Norway | 28.4.2020 |
| EU/2/14/178 | Zulvac SBV | Iceland | 21.1.2020 |
| EU/2/14/178 | Zulvac SBV | Liechtenstein | 29.2.2020 |
| EU/2/14/178 | Zulvac SBV | Norway | 12.2.2020 |
| EU/1/19/1367 | Zynteglo | Iceland | 22.5.2020 |
| EU/1/19/1367 | Zynteglo | Liechtenstein | 30.4.2020 |
| EU/1/19/1367 | Zynteglo | Norway | 11.5.2020 |

EU-Number

Product

Country

Date of authorisation

EU/1/15/1001

Akynzeo

Iceland

15.1.2020

EU/1/15/1001

Akynzeo

Liechtenstein

29.2.2020

EU/1/15/1001

Akynzeo

Norway

22.1.2020

EU/1/15/1005

Aripiprazole Mylan Pharma

Iceland

13.3.2020

EU/1/15/1005

Aripiprazole Mylan Pharma

Norway

10.3.2020

EU/1/15/1029

Aripiprazole Sandoz

Liechtenstein

30.6.2020

EU/1/15/1009

Aripiprazole Zentiva

Iceland

22.6.2020

EU/1/15/1009

Aripiprazole Zentiva

Liechtenstein

30.6.2020

EU/1/15/1009

Aripiprazole Zentiva

Norway

18.6.2020

EU/1/15/1019

Bortezomib Accord

Iceland

20.5.2020

EU/1/15/1019

Bortezomib Accord

Liechtenstein

30.6.2020

EU/1/15/1019

Bortezomib Accord

Norway

15.5.2020

EU/1/13/818

Bosulif

Iceland

27.2.2020

EU/1/13/818

Bosulif

Liechtenstein

29.2.2020

EU/1/13/818

Bosulif

Norway

25.2.2020

EU/1/10/645

Brinavess

Iceland

22.6.2020

EU/1/10/645

Brinavess

Liechtenstein

30.6.2020

EU/1/10/645

Brinavess

Norway

8.6.2020

EU/2/15/183

Canigen L4

Liechtenstein

30.4.2020

EU/2/15/183

Canigen L4

Norway

28.4.2020

EU/1/11/749

Caprelsa

Iceland

21.1.2020

EU/1/11/749

Caprelsa

Liechtenstein

29.2.2020

EU/1/11/749

Caprelsa

Norway

23.1.2020

EU/1/14/974

Cerdelga

Norway

3.1.2020

EU/2/14/180

Coliprotec F4

Iceland

24.1.2020

EU/2/14/180

Coliprotec F4

Liechtenstein

29.2.2020

EU/2/14/180

Coliprotec F4

Norway

12.2.2020

EU/1/13/890

Cometriq

Iceland

20.3.2020

EU/1/13/890

Cometriq

Liechtenstein

29.2.2020

EU/1/13/890

Cometriq

Liechtenstein

30.4.2020

EU/1/13/890

Cometriq

Norway

10.3.2020

EU/1/15/1048

Cotellic

Liechtenstein

30.6.2020

EU/1/17/1262

Crysvita

Norway

20.1.2020

EU/1/10/636

Daxas

Iceland

2.6.2020

EU/1/10/636

Daxas

Liechtenstein

30.6.2020

EU/1/10/636

Daxas

Norway

3.6.2020

EU/1/13/875

Deltyba

Iceland

19.5.2020

EU/1/13/875

Deltyba

Liechtenstein

30.4.2020

EU/1/13/875

Deltyba

Norway

30.4.2020

EU/1/15/1010

Duloxetine Mylan

Iceland

27.2.2020

EU/1/15/1010

Duloxetine Mylan

Liechtenstein

29.2.2020

EU/1/15/1010

Duloxetine Mylan

Norway

24.2.2020

EU/1/15/1025

Evotaz

Norway

8.4.2020

EU/1/15/1058

Entresto

Liechtenstein

30.6.2020

EU/1/15/1023

Farydak

Iceland

22.5.2020

EU/1/15/1023

Farydak

Liechtenstein

30.4.2020

EU/1/15/1023

Farydak

Norway

7.5.2020

EU/1/15/1007

Gardasil 9

Iceland

23.1.2020

EU/1/15/1007

Gardasil 9

Liechtenstein

29.2.2020

EU/1/15/1007

Gardasil 9

Norway

23.1.2020

EU/1/14/987

Holoclar

Iceland

13.3.2020

EU/1/14/987

Holoclar

Liechtenstein

30.4.2020

EU/1/14/987

Holoclar

Norway

16.3.2020

EU/1/15/990

Ikervis

Iceland

13.3.2020

EU/2/15/182

Innovax-ILT

Iceland

30.4.2020

EU/2/15/182

Innovax-ILT

Liechtenstein

30.4.2020

EU/2/15/182

Innovax-ILT

Norway

5.5.2020

EU/1/15/1041

Ivabradine Anpharm

Norway

2.6.2020

EU/1/15/1040

Intuniv

Liechtenstein

30.6.2020

EU/1/15/1000

Jinarc

Iceland

22.5.2020

EU/1/15/1000

Jinarc

Liechtenstein

30.4.2020

EU/1/15/1000

Jinarc

Norway

14.4.2020

EU/1/15/1033

Kanuma

Iceland

22.5.2020

EU/1/15/1033

Kanuma

Liechtenstein

30.4.2020

EU/1/15/1033

Kanuma

Norway

23.4.2020

EU/1/15/994

Kengrexal

Norway

13.1.2020

EU/1/15/1024

Keytruda

Iceland

16.4.2020

EU/1/15/1024

Keytruda

Norway

2.4.2020

EU/1/15/1060

Kyprolis

Liechtenstein

30.6.2020

EU/1/15/1002

Lenvima

Iceland

3.6.2020

EU/1/15/1002

Lenvima

Liechtenstein

30.6.2020

EU/1/15/1002

Lenvima

Norway

2.6.2020

EU/1/19/1376

Libtayo

Iceland

2.6.2020

EU/1/19/1376

Libtayo

Liechtenstein

30.6.2020

EU/1/19/1376

Libtayo

Norway

2.6.2020

EU/1/15/993

Lixiana

Iceland

13.3.2020

EU/1/15/993

Lixiana

Norway

10.3.2020

EU/1/19/1355

Lorviqua

Iceland

19.5.2020

EU/1/19/1355

Lorviqua

Norway

16.4.2020

EU/1/15/1013

Lumark

Iceland

19.5.2020

EU/1/15/1013

Lumark

Liechtenstein

30.4.2020

EU/1/15/1013

Lumark

Norway

5.5.2020

EU/1/14/988

Mysimba

Iceland

23.1.2020

EU/1/14/988

Mysimba

Liechtenstein

29.2.2020

EU/1/14/988

Mysimba

Norway

23.1.2020

EU/1/15/1078

Natpar

Iceland

24.6.2020

EU/1/15/1078

Natpar

Liechtenstein

30.4.2020

EU/2/15/186

Novaquin

Liechtenstein

30.6.2020

EU/1/16/1139

Ocaliva

Iceland

20.5.2020

EU/1/16/1139

Ocaliva

Liechtenstein

30.4.2020

EU/1/16/1139

Ocaliva

Norway

12.5.2020

EU/1/15/1030

Odomzo

Iceland

16.6.2020

EU/1/15/1030

Odomzo

Liechtenstein

30.6.2020

EU/1/15/1030

Odomzo

Norway

3.6.2020

EU/1/18/1345

Ondexxya

Iceland

25.5.2020

EU/1/18/1345

Ondexxya

Liechtenstein

30.4.2020

EU/1/15/1014

Opdivo

Iceland

19.5.2020

EU/1/15/1014

Opdivo

Liechtenstein

30.4.2020

EU/1/15/1014

Opdivo

Norway

8.5.2020

EU/1/15/989

Orbactiv

Iceland

21.1.2020

EU/1/15/989

Orbactiv

Liechtenstein

29.2.2020

EU/1/15/989

Orbactiv

Norway

22.1.2020

EU/1/16/1089

Pandemic influenza vaccine H5N1 AstraZeneca

Iceland

20.3.2020

EU/1/16/1089

Pandemic influenza vaccine H5N1 AstraZeneca

Liechtenstein

29.2.2020

EU/1/16/1089

Pandemic influenza vaccine H5N1 AstraZeneca

Liechtenstein

30.4.2020

EU/1/16/1089

Pandemic influenza vaccine H5N1 AstraZeneca

Norway

24.3.2020

EU/1/15/1034

Pemetrexed Lilly

Iceland

22.6.2020

EU/1/15/1034

Pemetrexed Lilly

Liechtenstein

30.6.2020

EU/1/15/1034

Pemetrexed Lilly

Norway

15.6.2020

EU/2/15/187

Porcilis PCV ID

Iceland

22.6.2020

EU/2/15/187

Porcilis PCV ID

Liechtenstein

30.6.2020

EU/1/15/1031

Praluent

Iceland

23.6.2020

EU/1/15/1031

Praluent

Liechtenstein

30.6.2020

EU/1/15/1031

Praluent

Norway

18.6.2020

EU/1/15/997

Pregabalin Mylan

Iceland

16.4.2020

EU/1/15/997

Pregabalin Mylan

Liechtenstein

30.4.2020

EU/1/15/997

Pregabalin Mylan

Norway

16.4.2020

EU/1/15/998

Pregabalin Mylan Pharma

Iceland

22.5.2020

EU/1/15/998

Pregabalin Mylan Pharma

Liechtenstein

30.4.2020

EU/1/15/998

Pregabalin Mylan Pharma

Norway

16.4.2020

EU/1/14/916

Pregabalin Pfizer

Norway

10.6.2020

EU/1/15/1011

Pregabalin Sandoz

Liechtenstein

30.6.2020

EU/1/15/1012

Pregabalin Sandoz GmbH

Liechtenstein

30.6.2020

EU/1/15/1021

Pregabalin Zentiva

Iceland

16.6.2020

EU/1/15/1021

Pregabalin Zentiva

Liechtenstein

30.6.2020

EU/1/15/1021

Pregabalin Zentiva

Norway

2.6.2020

EU/2/15/187

Porcilis PCV ID

Norway

9.6.2020

EU/1/10/618

Prolia

Iceland

23.1.2020

EU/1/10/618

Prolia

Liechtenstein

29.2.2020

EU/1/14/973

Quinsair

Iceland

19.2.2020

EU/1/14/973

Quinsair

Liechtenstein

29.2.2020

EU/1/14/973

Quinsair

Norway

19.2.2020

EU/1/15/1016

Repatha

Iceland

22.4.2020

EU/1/15/1016

Repatha

Liechtenstein

30.4.2020

EU/1/15/1016

Repatha

Norway

22.4.2020

EU/1/15/1006

Respreeza

Iceland

22.5.2020

EU/1/15/1006

Respreeza

Liechtenstein

30.4.2020

EU/1/15/1006

Respreeza

Norway

28.4.2020

EU/1/17/1250

Rubraca

Iceland

22.5.2020

EU/1/17/1250

Rubraca

Liechtenstein

30.4.2020

EU/1/17/1250

Rubraca

Norway

23.4.2020

EU/1/15/992

Saxenda

Norway

3.1.2020

EU/2/15/181

Sileo

Iceland

19.5.2020

EU/2/15/181

Sileo

Liechtenstein

30.4.2020

EU/2/15/181

Sileo

Norway

12.5.2020

EU/1/13/901

Sirturo

Iceland

15.1.2020

EU/1/13/901

Sirturo

Liechtenstein

29.2.2020

EU/1/13/901

Sirturo

Norway

23.1.2020

EU/1/15/991

Sivextro

Iceland

15.1.2020

EU/1/15/991

Sivextro

Liechtenstein

29.2.2020

EU/1/15/991

Sivextro

Norway

22.1.2020

EU/1/15/1015

Strensiq

Iceland

20.5.2020

EU/1/15/1015

Strensiq

Norway

5.5.2020

EU/1/15/1003

Synjardy

Iceland

16.4.2020

EU/1/15/1003

Synjardy

Liechtenstein

30.4.2020

EU/1/15/1003

Synjardy

Norway

14.4.2020

EU/1/15/1004

Voriconazole Hikma

Iceland

25.5.2020

EU/1/15/1004

Voriconazole Hikma

Norway

24.3.2020

EU/1/19/1360

Waylivra

Iceland

21.3.2020

EU/1/19/1360

Waylivra

Liechtenstein

30.4.2020

EU/1/19/1360

Waylivra

Norway

26.5.2020

EU/1/15/1032

Zerbaxa

Iceland

30.4.2020

EU/1/15/1032

Zerbaxa

Liechtenstein

30.4.2020

EU/1/15/1032

Zerbaxa

Norway

28.4.2020

EU/2/14/178

Zulvac SBV

Iceland

21.1.2020

EU/2/14/178

Zulvac SBV

Liechtenstein

29.2.2020

EU/2/14/178

Zulvac SBV

Norway

12.2.2020

EU/1/19/1367

Zynteglo

Iceland

22.5.2020

EU/1/19/1367

Zynteglo

Liechtenstein

30.4.2020

EU/1/19/1367

Zynteglo

Norway

11.5.2020

---

ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January-30 June 2020:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/15/1001/003 | Akynzeo | Iceland | 16.4.2020 |
| EU/1/15/1001/003 | Akynzeo | Norway | 23.3.2020 |
| EU/1/16/1101/004 | Darzalex | Iceland | 23.6.2020 |
| EU/1/11/733/005 | Dificlir | Iceland | 20.3.2020 |
| EU/1/11/733/005 | Dificlir | Norway | 20.2.2020 |
| EU/1/14/923/002-007 | Entyvio | Iceland | 24.6.2020 |
| EU/1/14/923/002-007 | Entyvio | Norway | 28.4.2020 |
| EU/1/18/1288/007 | Halimatoz | Iceland | 20.4.2020 |
| EU/1/18/1287/007 | Hefiya | Iceland | 20.4.2020 |
| EU/1/18/1286/007 | Hyrimoz | Iceland | 20.4.2020 |
| EU/1/16/1147/010-018 | Ibrance | Iceland | 22.4.2020 |
| EU/1/16/1147/010-015 | Ibrance | Norway | 19.2.2020 |
| EU/1/17/1254/007-011 | Jorveza | Iceland | 16.6.2020 |
| EU/1/17/1254/007-011 | Jorveza | Norway | 2.6.2020 |
| EU/1/12/782/006 | Kalydeco | Iceland | 2.1.2020 |
| EU/1/16/1115/003-005 | Pemetrexed Fresenius Kabi | Iceland | 19.2.2020 |
| EU/1/16/1115/003-005 | Pemetrexed Fresenius Kabi | Norway | 19.2.2020 |
| EU/1/11/717/003-004 | Vyndaqel | Iceland | 22.4.2020 |
| EU/1/11/717/003-004 | Vyndaqel | Norway | 24.2.2020 |
| EU/1/17/1178/010-013 | XELJANZ | Iceland | 2.1.2020 |

EU-Number

Product

Country

Date of authorisation

EU/1/15/1001/003

Akynzeo

Iceland

16.4.2020

EU/1/15/1001/003

Akynzeo

Norway

23.3.2020

EU/1/16/1101/004

Darzalex

Iceland

23.6.2020

EU/1/11/733/005

Dificlir

Iceland

20.3.2020

EU/1/11/733/005

Dificlir

Norway

20.2.2020

EU/1/14/923/002-007

Entyvio

Iceland

24.6.2020

EU/1/14/923/002-007

Entyvio

Norway

28.4.2020

EU/1/18/1288/007

Halimatoz

Iceland

20.4.2020

EU/1/18/1287/007

Hefiya

Iceland

20.4.2020

EU/1/18/1286/007

Hyrimoz

Iceland

20.4.2020

EU/1/16/1147/010-018

Ibrance

Iceland

22.4.2020

EU/1/16/1147/010-015

Ibrance

Norway

19.2.2020

EU/1/17/1254/007-011

Jorveza

Iceland

16.6.2020

EU/1/17/1254/007-011

Jorveza

Norway

2.6.2020

EU/1/12/782/006

Kalydeco

Iceland

2.1.2020

EU/1/16/1115/003-005

Pemetrexed Fresenius Kabi

Iceland

19.2.2020

EU/1/16/1115/003-005

Pemetrexed Fresenius Kabi

Norway

19.2.2020

EU/1/11/717/003-004

Vyndaqel

Iceland

22.4.2020

EU/1/11/717/003-004

Vyndaqel

Norway

24.2.2020

EU/1/17/1178/010-013

XELJANZ

Iceland

2.1.2020

---

ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January-30 June 2020:

| EU-Number | Product | Country | Date of withdrawal |
| --- | --- | --- | --- |
| EU/1/09/541 | Clopidogrel ratiopharm GmbH | Iceland | 23.1.2020 |
| EU/1/09/541 | Clopidogrel ratiopharm GmbH | Liechtenstein | 29.2.2020 |
| EU/1/09/541 | Clopidogrel ratiopharm GmbH | Norway | 13.1.2020 |
| EU/1/09/510 | Fertavid | Iceland | 30.1.2020 |
| EU/1/09/510 | Fertavid | Norway | 23.1.2020 |
| EU/1/15/1039 | Fexeric | Iceland | 27.2.2020 |
| EU/1/00/144 | Helixate NexGen | Iceland | 3.1.2020 |
| EU/1/19/1357 | KROMEYA | Iceland | 3.1.2020 |
| EU/1/16/1165 | Lifmior | Iceland | 27.2.2020 |
| EU/1/04/287 | Osseor | Iceland | 22.5.2020 |
| EU/1/04/287 | Osseor | Norway | 8.5.2020 |
| EU/1/12/796 | Picato | Iceland | 20.2.2020 |
| EU/1/12/796 | Picato | Liechtenstein | 29.2.2020 |
| EU/1/12/796 | Picato | Norway | 11.2.2020 |
| EU/1/04/288 | Protelos | Iceland | 22.5.2020 |
| EU/1/04/288 | Protelos | Norway | 8.5.2020 |
| EU/2/09/099 | Suvaxyn PCV | Norway | 28.4.2020 |
| EU/1/17/1180 | Varuby | Iceland | 30.1.2020 |
| EU/1/17/1180 | Varuby | Norway | 23.1.2020 |
| EU/1/11/671 | Xiapex | Iceland | 6.1.2020 |
| EU/1/96/009 | Zerit | Liechtenstein | 30.6.2020 |
| EU/2/11/130 | Zulvac 1 Bovis | Iceland | 20.3.2020 |
| EU/2/11/130 | Zulvac 1 Bovis | Norway | 18.2.2020 |
| EU/2/11/131 | Zulvac 1 Ovis | Iceland | 20.3.2020 |
| EU/2/11/131 | Zulvac 1 Ovis | Norway | 13.3.2020 |

EU-Number

Product

Country

Date of withdrawal

EU/1/09/541

Clopidogrel ratiopharm GmbH

Iceland

23.1.2020

EU/1/09/541

Clopidogrel ratiopharm GmbH

Liechtenstein

29.2.2020

EU/1/09/541

Clopidogrel ratiopharm GmbH

Norway

13.1.2020

EU/1/09/510

Fertavid

Iceland

30.1.2020

EU/1/09/510

Fertavid

Norway

23.1.2020

EU/1/15/1039

Fexeric

Iceland

27.2.2020

EU/1/00/144

Helixate NexGen

Iceland

3.1.2020

EU/1/19/1357

KROMEYA

Iceland

3.1.2020

EU/1/16/1165

Lifmior

Iceland

27.2.2020

EU/1/04/287

Osseor

Iceland

22.5.2020

EU/1/04/287

Osseor

Norway

8.5.2020

EU/1/12/796

Picato

Iceland

20.2.2020

EU/1/12/796

Picato

Liechtenstein

29.2.2020

EU/1/12/796

Picato

Norway

11.2.2020

EU/1/04/288

Protelos

Iceland

22.5.2020

EU/1/04/288

Protelos

Norway

8.5.2020

EU/2/09/099

Suvaxyn PCV

Norway

28.4.2020

EU/1/17/1180

Varuby

Iceland

30.1.2020

EU/1/17/1180

Varuby

Norway

23.1.2020

EU/1/11/671

Xiapex

Iceland

6.1.2020

EU/1/96/009

Zerit

Liechtenstein

30.6.2020

EU/2/11/130

Zulvac 1 Bovis

Iceland

20.3.2020

EU/2/11/130

Zulvac 1 Bovis

Norway

18.2.2020

EU/2/11/131

Zulvac 1 Ovis

Iceland

20.3.2020

EU/2/11/131

Zulvac 1 Ovis

Norway

13.3.2020

---

ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 January-30 June 2020:

| EU-Number | Product | Country | Date of suspension |
| --- | --- | --- | --- |
| EU/1/12/750 | Esmya | Norway | 2.4.2020 |
| EU/1/12/796 | Picato | Norway | 22.1.2020 |
| EU/1/18/1309 | Ulipristal Acetate Richter | Norway | 28.5.2020 |

EU-Number

Product

Country

Date of suspension

EU/1/12/750

Esmya

Norway

2.4.2020

EU/1/12/796

Picato

Norway

22.1.2020

EU/1/18/1309

Ulipristal Acetate Richter

Norway

28.5.2020

---